Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2003
11/06/2003WO2002061105A3 Chimeric molecules containing a module able to target specific cells and a module regulating the apoptogenic function of the permeability transition pore complex (ptpc)
11/06/2003WO2002061098A3 Promoters from cyanobacteria allowing high expression levels
11/06/2003WO2002061070A8 Environmentally regulated genes, involved in the virulence of streptococcus suis
11/06/2003WO2002060949A8 Glycoforms a fas ligand inhibitory protein analog
11/06/2003WO2002059558A8 Means and methods for treatment evaluation
11/06/2003WO2002059312A3 Cell adhesion proteins
11/06/2003WO2002059270A8 Methods and compositions for expressing polynucleotides specifically in smooth muscle cells in vivo
11/06/2003WO2002059266A3 Dna encoding human alpha and beta subunits of neuronal nicotinic acetylcholine receptor
11/06/2003WO2002057792A3 Affinity selection-based screening of hydrophobic proteins
11/06/2003WO2002057489A3 Method of determining a chemotherapeutic regimen based on ercc1 and ts expression
11/06/2003WO2002057469A8 Modulating developmental transitions in plants
11/06/2003WO2002053742A3 Proteins and nucleic acids encoding same
11/06/2003WO2002052931A3 Transgenic mice containing gprc5b-like gene disruptions
11/06/2003WO2002050260A3 Process for the production and purification of secreted proteins ans the production of arrays of proteins
11/06/2003WO2002050247A3 Antisense modulation of hepsin expression
11/06/2003WO2002047477A3 Transgenic mice containing huntingtin interacting protein 1 gene disruptions
11/06/2003WO2002047476A3 Transgenic mice containing serine/threonine kinase (stk) target gene disruptions
11/06/2003WO2002046475A3 Method of detecting and treating tuberous sclerosis complex associated disorders
11/06/2003WO2002046437A3 Methods and compositions for highly efficient production of heterologous proteins in yeast
11/06/2003WO2002046389A9 Genes associated with allergic hypersensitivity and mast cell activation
11/06/2003WO2002046379A3 Glucuronyl c5-epimerase, dna encoding the same and uses thereof
11/06/2003WO2002044413A3 Method of determining epidermal growth factor receptor and her2-neu gene expression and correlation of levels thereof with survival rates
11/06/2003WO2002044210A3 Novel human nucleic acid molecules and polypeptides encoding a novel human ion channel expressed in spinal cord and brain
11/06/2003WO2002044199A3 Neurotoxins with enhanced target specificity
11/06/2003WO2002031190A3 Methods of identification and isolation of polynucleotides containing nucleic acid differences
11/06/2003WO2002026933A3 Isoprenoid production
11/06/2003WO2002026785A3 Epitopes of virus hepatitis c specifically cd4+ t lymphocytes
11/06/2003WO2002024891A9 B7-like molecules and uses thereof
11/06/2003WO2002024883A3 Lactic acid bacteria capable of reducing an individual's tendency to develop allergic reactions
11/06/2003WO2002024750A3 Human kidney tumor overexpressed membrane protein 1
11/06/2003WO2002018643A9 Nanoparticles having oligonucleotides attached thereto and uses therefor
11/06/2003WO2002009639A3 Methods and pharmaceutical compositions for healing wounds
11/06/2003WO2002005749A3 Crf2 ligands in combination therapy
11/06/2003WO2002004952A3 Diagnostic and therapeutic methods based on the l1 adhesion molecule for ovarian and endometrial tumors
11/06/2003WO2001095701A8 Methods for somatic embryo formation and plant regeneration of beta vulgaris
11/06/2003WO2001085773A8 Luxo-sigma54 interactions and methods of use
11/06/2003WO2001080633A8 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema
11/06/2003WO2001078503A3 Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins
11/06/2003WO2000028012A8 THE USE OF β-GLUCOSIDASE TO ENHANCE DISEASE RESISTANCE AND RESISTANCE TO INSECTS IN CROP PLANTS
11/06/2003WO2000026247A8 Ikaros isoforms and mutants
11/06/2003WO2000023569A8 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema
11/06/2003US20030208797 Production of antibodies
11/06/2003US20030208794 Gene targeting using replicating DNA molecules
11/06/2003US20030208793 Transformed Brassica CC genome comprising Brassica AA transparent seed coat gene
11/06/2003US20030208792 A coat protein (CP) or a movement protein (MP) gene is replaced with a nuclear inclusion protease (NIa) expression cassette for the expression of a heterologous peptide in a tobacco ; for purposes of creating a vaccinevaccine
11/06/2003US20030208791 Enzymes involved in triterpene synthesis
11/06/2003US20030208790 Insect resistant plants and methods for making same
11/06/2003US20030208789 Producing plants in which expression of an insecticidal protein is regulated by the wound- inducible orphan receptor (TR2) promoter
11/06/2003US20030208787 Dehiscence gene and methods for regulating dehiscence
11/06/2003US20030208786 Transgenic pig containing heat shock protein 70 transgene
11/06/2003US20030208785 Transgenic pig containing heat shock protein 70 transgene
11/06/2003US20030208784 Producing or selecting cells or transgenic animals containing inhibited genes for the analysis of gene function
11/06/2003US20030208783 Transcriptional activator fusion proteins which comprises both tetracycline controlled transactivator proteins and reverse tetracycline transactivator proteins
11/06/2003US20030208781 By immunization with any desired antigen
11/06/2003US20030208780 Useful in preparing recombinant cells for diagnosis and therapy of human tumors
11/06/2003US20030208059 Gene therapy approaches to supply apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
11/06/2003US20030208058 B7-like polypeptides and polynucleotides
11/06/2003US20030208055 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030208054 Fc Receptors and polypeptides
11/06/2003US20030208051 Human hepatocyte growth factor activator inhibitor homologue
11/06/2003US20030208048 Anti-alphavbeta3 recombinant human antibodies, nucleic acids encoding same and methods of use
11/06/2003US20030208045 Binds to Osteoclastogenesis Inhibitory Factor (OCIF) binding molecule (OBM)
11/06/2003US20030208043 Human genes, sequences and expression products
11/06/2003US20030208041 Chloride channel polypeptides and nucleic acids, and their uses in obtaining compounds for preventing or treating a tick infestation
11/06/2003US20030208035 Antifungal and/or antibacterial peptides, preparation methods, compositions containing same and methods of treating mammals and/or plants
11/06/2003US20030207885 Nitrogen compounds such as 6-chloro-3-ethyl-2-(2-thiazol-2-yl -imidazol-1-ylmethyl)-imidazo(1,2-b)pyridazine used for prophylaxis of nervous system disorders
11/06/2003US20030207841 Novel nucleoside and oligonucleotide analogues
11/06/2003US20030207839 Antisense modulation of Jagged 2 expression
11/06/2003US20030207837 Method and reagent for the induction of graft tolerance and reversal of immune responses
11/06/2003US20030207836 Ovo nucleotide immuno-stimulant. The VAF contains one or more DNA constructs, each having a DNA molecule and a vector. Each of the DNA molecule contains one or more genes or gene fragments, each encoding an antigenic peptide of an avian
11/06/2003US20030207835 Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and detection of bladder and other cancers
11/06/2003US20030207834 The present invention relates to methods and compositions containing oligonucleotides suitable for administration to humans and other mammals.
11/06/2003US20030207833 Composition comprising a minicell, wherein said minicell displays a membrane protein, wherein said membrane protein is selected from the group consisting of a eukaryotic membrane protein, an archeabacterial membrane protein and an
11/06/2003US20030207832 Inducible gene expression constructs and methods of inducing gene expression using a combination of inducing agents.
11/06/2003US20030207824 Pyrimidine derivatives for labeled binding partners
11/06/2003US20030207807 A feline hepatocyte growth factor gene and a 15 base pairs-deleted feline hepatocyte growth factor gene. These genes encode the following protein (a) or (b): a protein having an amino acid sequence shown in SEQ ID NO: 2 or 4; and a protein
11/06/2003US20030207806 Insecticidal protein toxins from Photorhabdus
11/06/2003US20030207801 Novel polypeptides and nucleic acids encoding same
11/06/2003US20030207795 Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditions
11/06/2003US20030207452 Methods for transforming plants plastids and making transplastomic plants
11/06/2003US20030207451 Methods, compositions, and kits for enhancing oligonucleotide-mediated nucleic acid sequence alteration using compositions comprising a histone deacetylase inhibitor, lambda phage beta protein, or hydroxyurea
11/06/2003US20030207448 Methodologies for the creation of pluripotent or multipotent human stem cells without creating or destroying a human embryo
11/06/2003US20030207447 Used to distinguish between arterial endothelial cells (arteries) and venous endothelial cells (veins)
11/06/2003US20030207446 Infectious papillomavirus pseudoviral particles
11/06/2003US20030207445 Through incorporation of complement regulatory protein into retroviral particles
11/06/2003US20030207444 With differences nullified due to looping and truncating bases
11/06/2003US20030207442 Method for detecting the presence of an analyte in a sample
11/06/2003US20030207438 Pseudotyped retroviral vectors
11/06/2003US20030207435 Have increased anti-coagulation activity and resistance to inactivation by serpins
11/06/2003US20030207434 Phosphodiesterases
11/06/2003US20030207429 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207428 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207427 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207426 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207425 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207424 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207423 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207422 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207421 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207420 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
1 ... 2381 2382 2383 2384 2385 2386 2387 2388 2389 2390 2391 2392 2393 2394 2395 2396 2397 2398 2399 2400 2401 ... 4023